Commercial Operations

Home » Topics » Pharmaceuticals » Commercial Operations

June 5, 2020
AstraZeneca Enters Agreements to Supply 1.3 Billion Doses of COVID-19 Vaccine
AstraZeneca has entered into two partnerships to manufacture and distribute 1.3 billion doses of its COVID-19 vaccine.
June 4, 2020
Novavax Partners With AGC Biologics to Manufacture COVID-19 Vaccine Component
AGC Biologics will scale up production of the adjuvant to help increase Novavax’s capacity to deliver vaccine doses this year.
June 3, 2020
Drugmakers Report Zoloft Shortage Amid COVID-19
Makers of Zoloft (sertraline hydrochloride) and its generic versions are reporting shortages linked to increased demand during the pandemic coupled with supply chain issues caused by the impact of COVID-19 on manufacturers of active pharmaceutical ingredients (APIs).

May 29, 2020
CordenPharma to Supply Excipients for Moderna’s COVID-19 Vaccine
May 29, 2020
Oxford Biomedica to Make AstraZeneca’s COVID-19 Vaccine
May 29, 2020
AveXis to Manufacture Mass General’s COVID-19 Vaccine
May 29, 2020
GSK Plans to Produce 1 Billion Doses of Vaccine Adjuvant
May 28, 2020
Novavax Buys Up Czech Company to Increase Vaccine Production

May 28, 2020
Novavax Acquires Praha Vaccines to Expand COVID-19 Manufacturing Capacity
May 27, 2020
Drugmaker in Bangladesh Manufactures Generic Remdesivir
May 22, 2020
TriNetX, Harvard Pilgrim Health Care Institute to Monitor COVID-19 Drug Usage
May 22, 2020
TriNetX, Harvard Pilgrim Health Care Institute to Monitor COVID-19 Drug Usage
May 20, 2020
HHS Awards Virginia Firm $354 Million to Manufacture Essential COVID-19 Medicines

16Jun
Dealing with FCPA and Other Investigations Under the New Normal